Early emergence of de novo EGFR T790M gatekeeper mutations during erlotinib treatment in PC9 non-small cell lung cancer cells
Keywords: EGFR (epidermal growth factor receptor); NSCLC (non-small cell lung cancer); Erlotinib; EGFR-Targeted therapy; De novo mutation; Erlotinib-resistance; T790M;